Thomas Desrosier
CIK 1435744 · Lihat di SEC EDGAR ↗
Pengajuan SEC Pertama: 8 Feb. 2021 · Terbaru: 8 Feb. 2021
Di halaman ini
- Orang Dalam di Perusahaan di mana orang ini adalah orang dalam yang melaporkan.
- Transaksi orang dalam Setiap saham yang dibeli atau dijual orang ini, dari pengajuan Formulir 4.
- Derivatif Opsi dan kepemilikan derivatif lainnya yang dilaporkan oleh orang ini.
- Kompensasi Gaji eksekutif yang diungkapkan dalam pernyataan proksi perusahaan.
Orang Dalam di
Transaksi orang dalam
Perubahan harga vs kuotasi saat ini, disesuaikan split untuk aksi korporasi sejak pengajuan — tidak dibenchmark, tidak diannualisasi, tidak dibobot berdasarkan ukuran
| Tanggal | Ticker | Kode | Saham | Harga | Nilai | Dimiliki setelah | Δ milik | A/D | vs sekarang |
|---|---|---|---|---|---|---|---|---|---|
| 17 Agu 2026 | MCRB | S 10b5-1 | 82 | $4,55 | $373 | 8.117 Langsung | -1,00% | Dilepas | 0,9% (harga per 2026-08-19) |
| 18 Mei 2026 | MCRB | S 10b5-1 | 79 | $7,53 | $595 | 7.954 Langsung | -0,98% | Dilepas | -39,0% (harga per 2026-08-19) |
| 15 Feb. 2026 | MCRB | S 10b5-1 | 78 | $8,47 | $661 | 7.789 Langsung | -0,99% | Dilepas | -45,8% (harga per 2026-08-19) |
| 15 Nov. 2025 | MCRB | S 10b5-1 | 76 | $17,30 | $1.315 | 7.623 Langsung | -0,99% | Dilepas | -73,5% (harga per 2026-08-19) |
| 18 Agu 2025 | MCRB | S 10b5-1 | 76 | $16,65 | $1.265 | 7.455 Langsung | -1,01% | Dilepas | -72,4% (harga per 2026-08-19) |
| 15 Mei 2025 | MCRB | S 10b5-1 | 79 | $7,28 | $575 | 7.287 Langsung | -1,07% | Dilepas | -37,0% (harga per 2026-08-19) |
| 18 Feb. 2025 | MCRB | S 10b5-1 | 4.300 | $0,81 | $3.483 | 142.456 Langsung | -2,93% | Dilepas | -71,7% (harga per 2026-08-19) |
| 18 Nov. 2024 | MCRB | S 10b5-1 | 878 | $0,54 | $474 | 135.192 Langsung | -0,65% | Dilepas | -57,5% (harga per 2026-08-19) |
| 28 Okt. 2024 | MCRB | S 10b5-1 | 4.259 | $0,69 | $2.939 | 133.414 Langsung | -3,09% | Dilepas | -66,7% (harga per 2026-08-19) |
| 16 Agu 2024 | MCRB | S 10b5-1 | 873 | $0,84 | $733 | 124.173 Langsung | -0,70% | Dilepas | -72,7% (harga per 2026-08-19) |
| 15 Mei 2024 | MCRB | S 10b5-1 | 843 | $0,94 | $792 | 122.390 Langsung | -0,68% | Dilepas | -75,6% (harga per 2026-08-19) |
| 16 Feb. 2024 | MCRB | S 10b5-1 | 3.939 | $1,08 | $4.254 | 120.577 Langsung | -3,16% | Dilepas | -78,8% (harga per 2026-08-19) |
| 30 Okt. 2023 | MCRB | S 10b5-1 | 4.156 | $1,35 | $5.611 | 113.891 Langsung | -3,52% | Dilepas | -83,0% (harga per 2026-08-19) |
| 28 Jan. 2019 | MCRB | S | 5.471 | $5,75 | $31.458 | 16.054 Langsung | -25,42% | Dilepas | -96,0% (harga per 2026-08-19) |
| 26 Jan. 2018 | MCRB | S | 3.475 | $11,02 | $38.294 | 6.525 Langsung | -34,75% | Dilepas | -97,9% (harga per 2026-08-19) |
P = Pembelian pasar terbuka · S = Penjualan · A = Hibah/penghargaan · B = Pelaksanaan opsi · G = Hadiah · F = Pemotongan pajak
Transaksi orang dalam bukan merupakan rekomendasi; penjualan sering kali didorong oleh alasan likuiditas atau pajak.
Kepemilikan Derivatif (Formulir 4 Tabel II)
Opsi, RSU, dan sekuritas konversi yang dilaporkan pada Formulir 4 Tabel II.
| Tanggal | Ticker | Sekuritas | Underlying | Harga Pelaksanaan | Kedaluwarsa | Saham | A/D |
|---|---|---|---|---|---|---|---|
| 15 Agu 2026 | MCRB | Restricted Stock Units | Common Stock (133) | — | — | 133 | Dilepas |
| 15 Agu 2026 | MCRB | Restricted Stock Units | Common Stock (112) | — | — | 112 | Dilepas |
| 8 Juli 2026 | MCRB | Stock Option (right to buy) | Common Stock (7.500) | $9,13 | 3 Maret 2036 | 7.500 | Diakuisisi |
| 15 Mei 2026 | MCRB | Restricted Stock Units | Common Stock (111) | — | — | 111 | Dilepas |
| 15 Mei 2026 | MCRB | Restricted Stock Units | Common Stock (133) | — | — | 133 | Dilepas |
| 4 Maret 2026 | MCRB | Stock Option (right to buy) | Common Stock (22.500) | $9,13 | 3 Maret 2036 | 22.500 | Diakuisisi |
| 15 Feb. 2026 | MCRB | Restricted Stock Units | Common Stock (111) | — | — | 111 | Dilepas |
| 15 Feb. 2026 | MCRB | Restricted Stock Units | Common Stock (133) | — | — | 133 | Dilepas |
| 15 Nov. 2025 | MCRB | Restricted Stock Units | Common Stock (112) | — | — | 112 | Dilepas |
| 15 Nov. 2025 | MCRB | Restricted Stock Units | Common Stock (132) | — | — | 132 | Dilepas |
| 15 Agu 2025 | MCRB | Restricted Stock Units | Common Stock (111) | — | — | 111 | Dilepas |
| 15 Agu 2025 | MCRB | Restricted Stock Units | Common Stock (133) | — | — | 133 | Dilepas |
| 15 Mei 2025 | MCRB | Restricted Stock Units | Common Stock (111) | — | — | 111 | Dilepas |
| 15 Mei 2025 | MCRB | Restricted Stock Units | Common Stock (133) | — | — | 133 | Dilepas |
| 15 Feb. 2025 | MCRB | Restricted Stock Units | Common Stock (8.907) | — | — | 8.907 | Dilepas |
| 15 Feb. 2025 | MCRB | Restricted Stock Units | Common Stock (2.657) | — | — | 2.657 | Dilepas |
| 7 Feb. 2025 | MCRB | Stock Option (Right to Buy) | Common Stock (650.000) | $0,78 | 6 Feb. 2035 | 650.000 | Diakuisisi |
| 15 Nov. 2024 | MCRB | Restricted Stock Units | Common Stock (2.656) | — | — | 2.656 | Dilepas |
| 27 Okt. 2024 | MCRB | Restricted Stock Units | Common Stock (13.500) | — | — | 13.500 | Dilepas |
| 15 Agu 2024 | MCRB | Restricted Stock Units | Common Stock (2.656) | — | — | 2.656 | Dilepas |
| 15 Mei 2024 | MCRB | Restricted Stock Units | Common Stock (2.656) | — | — | 2.656 | Dilepas |
| 15 Feb. 2024 | MCRB | Restricted Stock Units | Common Stock (10.625) | — | — | 10.625 | Dilepas |
| 14 Feb. 2024 | MCRB | Restricted Stock Units | Common Stock (35.625) | — | — | 35.625 | Diakuisisi |
| 14 Feb. 2024 | MCRB | Stock Option (Right to Buy) | Common Stock (287.905) | $1,10 | 13 Feb. 2034 | 287.905 | Diakuisisi |
| 14 Feb. 2024 | MCRB | Stock Option (Right to Buy) | Common Stock (213.750) | $1,10 | 13 Feb. 2034 | 213.750 | Diakuisisi |
| 27 Okt. 2023 | MCRB | Restricted Stock Units | Common Stock (13.501) | — | — | 13.501 | Dilepas |
| 27 April 2023 | MCRB | Restricted Stock Units | Common Stock (27.001) | — | — | 27.001 | Diakuisisi |
| 3 Feb. 2023 | MCRB | Stock Option (Right to Buy) | Common Stock (85.000) | $5,50 | 2 Feb. 2033 | 85.000 | Diakuisisi |
| 3 Feb. 2023 | MCRB | Restricted Stock Units | Common Stock (42.500) | — | — | 42.500 | Diakuisisi |
| 4 Feb. 2022 | MCRB | Stock Option (Right to Buy) | Common Stock (130.000) | $7,38 | 3 Feb. 2032 | 130.000 | Diakuisisi |
| 4 Feb. 2021 | MCRB | Stock Option (Right to Buy) | Common Stock (100.000) | $26,34 | 3 Feb. 2031 | 100.000 | Diakuisisi |
| 29 Jan. 2020 | MCRB | STOCK OPTION (RIGHT TO BUY) | Common Stock (350.000) | $3,30 | 28 Jan. 2030 | 350.000 | Diakuisisi |
| 26 Jan. 2020 | MCRB | RESTRICTED STOCK UNITS | Common Stock (25.000) | — | — | 25.000 | Dilepas |
| 26 Jan. 2019 | MCRB | RESTRICTED STOCK UNITS | Common Stock (15.000) | — | — | 15.000 | Dilepas |
| 25 Jan. 2019 | MCRB | STOCK OPTION (RIGHT TO BUY) | Common Stock (84.800) | $6,01 | 24 Jan. 2029 | 84.800 | Diakuisisi |
| 30 Jan. 2018 | MCRB | STOCK OPTION (RIGHT TO BUY) | COMMON STOCK (100.000) | $10,42 | 29 Jan. 2028 | 100.000 | Dilepas |
| 30 Jan. 2018 | MCRB | STOCK OPTION (RIGHT TO BUY) | COMMON STOCK (80.000) | $10,42 | 29 Jan. 2028 | 80.000 | Dilepas |
| 26 Jan. 2018 | MCRB | RESTRICTED STOCK UNITS | COMMON STOCK (10.000) | — | — | 10.000 | Dilepas |
| 26 Jan. 2017 | MCRB | Restricted Stock Units | Common Stock (50.000) | — | — | 50.000 | Diakuisisi |
| 26 Jan. 2017 | MCRB | Stock Option (right to buy) | Common Stock (60.000) | $9,89 | 25 Jan. 2027 | 60.000 | Diakuisisi |
| 1 Juni 2016 | MCRB | Stock Option (right to buy) | Common Stock (100.000) | $30,90 | 31 Mei 2026 | 100.000 | Diakuisisi |
Harga pelaksanaan/konversi kosong jika tidak berlaku (misalnya, RSU).
Kompensasi (DEF 14A)
Dicocokkan berdasarkan nama dari pernyataan proksi (DEF 14A) — verifikasi terhadap pengajuan.
| Tahun fiskal | Gaji | Bonus | Penghargaan saham | Penghargaan opsi | Insentif non-ekuitas | Perubahan Pensiun | Lainnya | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $512.900 | $166.667 | — | — | — | — | $10.166 | $1.136.023 |
| 2024 | $498.000 | — | — | — | $199.200 | — | $9.942 | $1.248.507 |
| 2020 | $450.000 | — | — | — | $261.000 | — | $8.550 | $1.437.260 |
Angka-angka dari Tabel Kompensasi Ringkasan dalam pernyataan proksi perusahaan (DEF 14A). Kompensasi bukan merupakan rekomendasi.